Company · CIK 0001346830 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Tvardi Therapeutics, Inc. · TVRD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 SForm 4 → | Mar 5, 4:53 pm EST | Derek T ChalmersPresident & CEO, Director | 9,792 | $17.04 | $166,856 | 943,996 | −1.03% | plan? |
| Feb 28, 2019 SForm 4 → | Mar 4, 5:49 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 1,500 | $17.50 | $26,250 | 142,779 | −1.04% | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 5:29 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 2,200 | $17.50 | $38,500 | 144,279 | −1.50% | plan? |
| Feb 1, 2019 SForm 4 → | Feb 5, 4:27 pm EST | Derek T ChalmersPresident & CEO, Director | 20,000 | $14.99 | $299,800 | 953,788 | −2.05% | plan? |
| Jan 2, 2019 SForm 4 → | Jan 4, 4:22 pm EST | Derek T ChalmersPresident & CEO, Director | 20,000 | $13.61 | $272,150 | 973,788 | −2.01% | plan? |
| Dec 28, 2018 SForm 4 → | Jan 2, 2019, 5:56 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 4,300 | $12.53 | $53,879 | 146,479 | −2.85% | plan? |
| Dec 28, 2018 SForm 4 → | Jan 2, 2019, 5:56 pm EST | Scott TerrillionSec'y; Chief Compliance & G.C. | 3,100 | $12.51 | $38,781 | 6,386 | −32.7% | plan? |
| Dec 28, 2018 SForm 4 → | Jan 2, 2019, 5:55 pm EST | Derek T ChalmersPresident & CEO, Director | 15,825 | $12.53 | $198,287 | 993,788 | −1.57% | plan? |
| Dec 28, 2018 SForm 4 → | Jan 2, 2019, 5:54 pm EST | Mani MohindruCFO & Chief Strategy Officer | 4,500 | $12.55 | $56,475 | 8,026 | −35.9% | plan? |
| Dec 27, 2018 AForm 4 → | Dec 31, 4:19 pm EST | Scott TerrillionSec'y; Chief Compliance & G.C. | 9,486 | — | — | 9,486 | — | plan? |
| Dec 27, 2018 AForm 4 → | Dec 31, 4:18 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 11,779 | — | — | 150,779 | — | plan? |
| Dec 27, 2018 AForm 4 → | Dec 31, 4:17 pm EST | Mani MohindruCFO & Chief Strategy Officer | 12,526 | — | — | 12,526 | — | plan? |
| Dec 27, 2018 AForm 4 → | Dec 31, 4:15 pm EST | Derek T ChalmersPresident & CEO, Director | 38,221 | — | — | 1,009,613 | — | plan? |
| Dec 3, 2018 SForm 4 → | Dec 6, 4:18 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $18.36 | $55,080 | 139,000 | −2.11% | plan? |
| Dec 3, 2018 SForm 4 → | Dec 6, 4:16 pm EST | Derek T ChalmersPresident & CEO, Director | 20,000 | $18.17 | $363,400 | 971,392 | −2.02% | plan? |
| Nov 15, 2018 SForm 4 → | Nov 16, 4:22 pm EST | Mani MohindruCFO & Chief Strategy Officer | 16,042 | $18.50 | $296,777 | 0 | −100% | plan? |
| Nov 15, 2018 MForm 4 → | Nov 16, 4:22 pm EST | Mani MohindruCFO & Chief Strategy Officer | 16,042 | $14.06 | $225,551 | 16,042 | — | plan? |
| Nov 1, 2018 SForm 4 → | Nov 5, 8:25 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $18.77 | $56,310 | 142,000 | −2.07% | plan? |
| Nov 1, 2018 MForm 4 → | Nov 5, 8:25 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 40,000 | $2.05 | $82,000 | 145,000 | — | plan? |
| Nov 1, 2018 SForm 4 → | Nov 2, 5:35 pm EDT | Derek T ChalmersPresident & CEO, Director | 20,000 | $18.78 | $375,600 | 991,392 | −1.98% | plan? |
| Oct 17, 2018 SForm 4 → | Oct 19, 4:34 pm EDT | Joseph William StaufferChief Medical Officer | 11,442 | $20.13 | $230,347 | 2,000 | −85.1% | plan? |
| Oct 17, 2018 SForm 4 → | Oct 19, 4:32 pm EDT | Mani MohindruCFO & Chief Strategy Officer | 16,042 | $20.19 | $323,888 | 0 | −100% | plan? |
| Oct 17, 2018 MForm 4 → | Oct 19, 4:32 pm EDT | Mani MohindruCFO & Chief Strategy Officer | 16,042 | $14.06 | $225,551 | 16,042 | — | plan? |
| Oct 1, 2018 SForm 4 → | Oct 3, 4:09 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $23.99 | $71,970 | 95,000 | −3.06% | plan? |
| Oct 1, 2018 SForm 4 → | Oct 3, 4:08 pm EDT | Derek T ChalmersPresident & CEO, Director | 20,000 | $23.79 | $475,800 | 1,011,392 | −1.94% | plan? |
| Sep 4, 2018 SForm 4 → | Sep 6, 5:34 pm EDT | Derek T ChalmersPresident & CEO, Director | 20,000 | $19.71 | $394,200 | 1,031,392 | −1.90% | plan? |
| Sep 4, 2018 SForm 4 → | Sep 6, 5:33 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $19.81 | $59,430 | 98,000 | −2.97% | plan? |
| Aug 20, 2018 SForm 4 → | Aug 22, 5:26 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $18.89 | $56,670 | 101,000 | −2.88% | plan? |
| Aug 6, 2018 MForm 4 → | Nov 5, 8:21 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 10,000 | $2.25 | $22,500 | 114,000 | — | plan? late |
| Jul 10, 2018 SForm 4 → | Jul 12, 4:42 pm EDT | Derek T ChalmersPresident & CEO, Director | 20,000 | $20.64 | $412,800 | 1,051,392 | −1.87% | plan? |
| Jul 2, 2018 SForm 4 → | Jul 5, 5:00 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $19.00 | $57,000 | 104,000 | −2.80% | plan? |
| Jun 1, 2018 SForm 4 → | Jun 5, 7:15 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $15.49 | $46,470 | 107,000 | −2.73% | plan? |
| May 23, 2018 SForm 4 → | May 25, 4:22 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 9,000 | $15.19 | $136,710 | 110,000 | −7.56% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 21, 5:13 pm EST | Derek T ChalmersPresident & CEO, Director | 5,400 | $15.00 | $81,000 | 1,071,392 | −0.50% | plan? |
| Feb 15, 2018 SForm 4 → | Feb 20, 4:43 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 3,000 | $15.02 | $45,060 | 119,000 | −2.46% | plan? |
| Jan 25, 2018 MForm 4 → | Jan 26, 5:52 pm EST | Derek T ChalmersPresident & CEO, Director | 3,000 | $6.00 | $18,000 | 1,076,792 | — | plan? |
| Jan 24, 2018 SForm 4 → | Jan 26, 5:53 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 15,000 | $15.00 | $225,000 | 122,000 | −10.9% | plan? |
| Jan 24, 2018 SForm 4 → | Jan 26, 5:52 pm EST | Derek T ChalmersPresident & CEO, Director | 12,500 | $15.00 | $187,500 | 1,073,792 | −1.15% | plan? |
| Nov 7, 2017 MForm 4 → | Nov 9, 4:36 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 20,000 | $2.48 | $49,600 | 137,000 | — | plan? |
| Nov 3, 2017 MForm 4 → | Nov 3, 5:27 pm EDT | Derek T ChalmersPresident & CEO, Director | 20,000 | $2.48 | $49,600 | 1,086,292 | — | plan? |
| Nov 1, 2017 SForm 4 → | Nov 3, 5:27 pm EDT | Derek T ChalmersPresident & CEO, Director | 16,000 | $12.66 | $202,560 | 1,066,292 | −1.48% | plan? |
| Aug 4, 2017 SForm 4 → | Aug 10, 5:47 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 3,000 | $15.00 | $45,000 | 117,000 | −2.50% | plan? late |
| Jul 26, 2017 MForm 4 → | Jul 28, 4:53 pm EDT | Josef SchoellChief Financial Officer | 4,000 | $2.25 | $9,000 | 50,000 | — | plan? |
| Jul 14, 2017 SForm 4 → | Jul 18, 6:10 pm EDT | Derek T ChalmersPresident & CEO, Director | 25,000 | $15.05 | $376,250 | 1,082,292 | −2.26% | plan? |
| Jul 14, 2017 MForm 4 → | Jul 18, 6:10 pm EDT | Derek T ChalmersPresident & CEO, Director | 10,000 | $2.48 | $24,800 | 1,107,292 | — | plan? |
| Jul 14, 2017 SForm 4 → | Jul 18, 6:09 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 3,000 | $15.00 | $45,000 | 120,000 | −2.44% | plan? |
| Jun 29, 2017 SForm 4 → | Jul 3, 5:53 pm EDT | Dean SlagelDirector | 250,000 | $25.87 | $6,468,564 | 1,064,338 | −19.0% | plan? |
| Mar 31, 2017 PForm 4 → | Apr 3, 9:19 am EDT | RHO Ventures VI LP +510% Owner | 500,000 | $18.19 | $9,095,700 | 3,568,057 | +16.3% | plan? |
| Apr 20, 2016 SForm 4 → | Apr 20, 5:34 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 6,000 | $9.00 | $54,000 | 123,000 | −4.65% | plan? |
| Mar 16, 2016 PForm 4 → | Mar 18, 7:43 pm EDT | Martin VogelbaumDirector | 400,000 | $4.87 | $1,949,203 | 3,068,057 | +15.0% | plan? |
| Mar 16, 2016 PForm 4 → | Mar 18, 7:22 pm EDT | RHO Ventures VI LP +510% Owner | 400,000 | $4.87 | $1,949,203 | 3,068,057 | +15.0% | plan? |
| Mar 16, 2016 MForm 4 → | Mar 17, 8:22 pm EDT | Josef SchoellChief Financial Officer | 18,000 | $0.8189 | $14,740 | 46,000 | — | plan? |
| Mar 15, 2016 MForm 4 → | Mar 17, 5:59 pm EDT | Derek T ChalmersPresident & CEO, Director | 10,000 | $2.48 | $24,800 | 1,097,292 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:41 pm EST | Frederique Menzaghi Ph.D.VP-Research & Development | 6,000 | $9.04 | $54,250 | 129,000 | −4.44% | plan? |
| Jan 26, 2016 SForm 4 → | Jan 27, 5:10 pm EST | Michael E LewisChief Scientific Advisor | 7,262 | $10.93 | $79,374 | 314,988 | −2.25% | plan? |
| Jan 6, 2016 SForm 4 → | Jan 7, 8:31 pm EST | Derek T ChalmersPresident & CEO, Director | 12,500 | $17.22 | $215,250 | 1,087,292 | −1.14% | plan? |
| Jan 4, 2016 SForm 4 → | Jan 5, 4:56 pm EST | Frederique Menzaghi Ph.D.VP-Research & Development | 6,000 | $16.80 | $100,800 | 135,000 | −4.26% | plan? |
| Dec 31, 2015 SForm 4/A → | Jan 12, 2016, 7:00 pm EST | Dean SlagelDirector | 44,000 | $17.01 | $748,312 | 1,314,338 | −3.24% | plan? |
| Dec 31, 2015 SForm 4 → | Jan 5, 2016, 4:54 pm EST | Dean SlagelDirector | 44,000 | $17.01 | $748,312 | 1,314,338 | −3.24% | plan? amended |
| Dec 1, 2015 SForm 4 → | Dec 3, 5:17 pm EST | Frederique Menzaghi Ph.D.VP-Research & Development | 6,000 | $16.21 | $97,260 | 141,000 | −4.08% | plan? |
| Nov 2, 2015 SForm 4 → | Nov 3, 6:08 pm EST | Frederique Menzaghi Ph.D.VP-Research & Development | 6,000 | $14.26 | $85,560 | 147,000 | −3.92% | plan? |
| Oct 1, 2015 SForm 4 → | Oct 5, 4:57 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 6,000 | $13.95 | $83,715 | 153,000 | −3.77% | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 5:52 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 7,000 | $18.63 | $130,410 | 159,000 | −4.22% | plan? |
| Aug 18, 2015 PForm 4 → | Aug 19, 6:03 pm EDT | Josef SchoellChief Financial Officer | 3,000 | $22.10 | $66,300 | 28,000 | +12.0% | plan? |
| Aug 4, 2015 PForm 4 → | Aug 6, 4:46 pm EDT | Joseph William StaufferChief Medical Officer | 2,000 | $18.60 | $37,200 | 13,442 | +17.5% | plan? |
| Aug 3, 2015 SForm 4 → | Aug 5, 5:16 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 7,000 | $21.41 | $149,870 | 166,000 | −4.05% | plan? |
| Jul 1, 2015 SForm 4 → | Jul 6, 5:06 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 7,000 | $12.22 | $85,540 | 173,000 | −3.89% | plan? |
| Jul 1, 2015 SForm 4 → | Jul 6, 5:03 pm EDT | Michael E LewisChief Scientific Advisor | 7,262 | $11.66 | $84,675 | 322,250 | −2.20% | plan? |
| Jun 1, 2015 SForm 4 → | Jun 2, 6:11 pm EDT | Michael E LewisChief Scientific Advisor | 7,262 | $9.50 | $68,989 | 329,512 | −2.16% | plan? |
| May 15, 2015 SForm 4 → | May 19, 5:11 pm EDT | Dean SlagelDirector | 188,811 | $10.02 | $1,891,428 | 1,358,338 | −12.2% | plan? |
| May 1, 2015 SForm 4 → | May 5, 4:49 pm EDT | Michael E LewisChief Scientific Advisor | 7,262 | $10.64 | $77,268 | 336,774 | −2.11% | plan? |
| Apr 1, 2015 SForm 4 → | Apr 2, 5:34 pm EDT | Michael E LewisChief Scientific Advisor | 7,262 | $9.90 | $71,894 | 344,036 | −2.07% | plan? |
| Mar 9, 2015 MForm 4 → | Mar 11, 4:54 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 20,000 | $0.25 | $5,000 | 180,000 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 3, 6:42 pm EST | Michael E LewisChief Scientific Advisor | 7,262 | $10.11 | $73,419 | 351,298 | −2.03% | plan? |
| Feb 17, 2015 SForm 4 → | Feb 19, 6:00 pm EST | Josef SchoellChief Financial Officer | 15,000 | $10.96 | $164,400 | 25,000 | −37.5% | plan? |
| Feb 2, 2015 SForm 4 → | Feb 3, 5:35 pm EST | Michael E LewisChief Scientific Advisor | 7,262 | $10.60 | $76,977 | 358,560 | −1.99% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 AForm 4 → | Jun 11, 4:30 pm EDT | Susan Shiff Ph.D.Director | 6,000 | — | — | 6,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:30 pm EDT | Cynthia SmithDirector | 6,000 | — | — | 6,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:30 pm EDT | Sujal ShahDirector | 6,000 | — | — | 6,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:30 pm EDT | Wallace L Hall Jr.Director | 6,000 | — | — | 6,000 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:30 pm EDT | Michael S WyzgaDirector | 6,000 | — | — | 6,000 | — | |
| Mar 6, 2019 AForm 4 → | Mar 8, 5:33 pm EST | Frederique Menzaghi Ph.D.Chief Scientific Off,SVP-R&D | 150,000 | — | — | 150,000 | — | |
| Mar 6, 2019 AForm 4 → | Mar 8, 5:32 pm EST | Mani MohindruCFO & Chief Strategy Officer | 75,000 | — | — | 75,000 | — | |
| Mar 6, 2019 AForm 4 → | Mar 8, 5:32 pm EST | Scott TerrillionSec'y; Chief Compliance & G.C. | 75,000 | — | — | 75,000 | — | |
| Mar 6, 2019 AForm 4 → | Mar 8, 5:31 pm EST | Derek T ChalmersPresident & CEO, Director | 235,000 | — | — | 235,000 | — | |
| Nov 15, 2018 MForm 4 → | Nov 16, 4:22 pm EST | Mani MohindruCFO & Chief Strategy Officer | 16,042 | — | — | 352,916 | — | |
| Nov 1, 2018 MForm 4 → | Nov 5, 8:25 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 40,000 | — | — | 0 | — | |
| Oct 22, 2018 AForm 4 → | Oct 24, 4:32 pm EDT | Joana GoncalvesChief Medical Officer | 250,000 | — | — | 250,000 | — | |
| Oct 17, 2018 MForm 4 → | Oct 19, 4:32 pm EDT | Mani MohindruCFO & Chief Strategy Officer | 16,042 | — | — | 368,958 | — | |
| Aug 6, 2018 MForm 4 → | Nov 5, 8:21 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 10,000 | — | — | 0 | — | late |
| Aug 2, 2018 AForm 4 → | Aug 6, 5:54 pm EDT | Christopher PosnerDirector | 35,000 | — | — | 35,000 | — | |
| Jun 6, 2018 AForm 4 → | Jun 8, 4:32 pm EDT | Jeffrey L. IvesDirector | 18,000 | — | — | 18,000 | — | |
| Jun 6, 2018 AForm 4 → | Jun 8, 4:31 pm EDT | Martin VogelbaumDirector | 18,000 | — | — | 18,000 | — | |
| Jun 6, 2018 AForm 4 → | Jun 8, 4:30 pm EDT | Harrison M Bains Jr.Director | 18,000 | — | — | 18,000 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 6:37 pm EDT | Scott TerrillionSec'y; Chief Compliance & G.C. | 46,500 | — | — | 46,500 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 6:37 pm EDT | Joseph William StaufferChief Medical Officer | 57,750 | — | — | 57,750 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 6:35 pm EDT | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 57,750 | — | — | 57,750 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 6:35 pm EDT | Derek T ChalmersPresident & CEO, Director | 187,500 | — | — | 187,500 | — | |
| Jan 25, 2018 MForm 4 → | Jan 26, 5:52 pm EST | Derek T ChalmersPresident & CEO, Director | 3,000 | — | — | 191,000 | — | |
| Nov 7, 2017 MForm 4 → | Nov 9, 4:36 pm EST | Frederique Menzaghi Ph.D.Sr VP-Research & Development | 20,000 | — | — | 0 | — | |
| Nov 3, 2017 MForm 4 → | Nov 3, 5:27 pm EDT | Derek T ChalmersPresident & CEO, Director | 20,000 | — | — | 0 | — | |
| Aug 15, 2017 AForm 4 → | Aug 24, 5:52 pm EDT | Mani MohindruCFO & Chief Strategy Officer | 385,000 | — | — | 385,000 | — | late |
| Jul 26, 2017 MForm 4 → | Jul 28, 4:53 pm EDT | Josef SchoellChief Financial Officer | 4,000 | — | — | 0 | — | |
| Jul 14, 2017 MForm 4 → | Jul 18, 6:10 pm EDT | Derek T ChalmersPresident & CEO, Director | 10,000 | — | — | 20,000 | — | |
| Jun 21, 2017 AForm 4 → | Jun 23, 6:37 pm EDT | Martin VogelbaumDirector | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2017 AForm 4 → | Jun 23, 6:36 pm EDT | Dean SlagelDirector | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2017 AForm 4 → | Jun 23, 6:35 pm EDT | Jeffrey L. IvesDirector | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2017 AForm 4 → | Jun 23, 6:34 pm EDT | Harrison M Bains Jr.Director | 15,000 | — | — | 15,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:22 pm EST | Derek T ChalmersPresident & CEO, Director | 225,000 | — | — | 225,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:21 pm EST | Michael E LewisChief Scientific Advisor | 20,000 | — | — | 20,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:21 pm EST | Josef SchoellChief Financial Officer | 55,000 | — | — | 55,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:20 pm EST | Frederique Menzaghi Ph.D.VP-Research & Development | 75,000 | — | — | 75,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:18 pm EST | Joseph William StaufferChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 6:33 pm EDT | Harrison M Bains Jr.Director | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 6:33 pm EDT | Martin VogelbaumDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 6:32 pm EDT | Dean SlagelDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 6:30 pm EDT | Jeffrey L. IvesDirector | 15,000 | — | — | 15,000 | — | |
| May 4, 2016 AForm 4 → | Jun 17, 6:31 pm EDT | Michael E LewisChief Scientific Advisor | 20,000 | — | — | 20,000 | — | late |
| Mar 30, 2016 AForm 4 → | Apr 1, 5:22 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 65,000 | — | — | 65,000 | — | |
| Mar 30, 2016 AForm 4 → | Apr 1, 5:21 pm EDT | Josef SchoellChief Financial Officer | 48,000 | — | — | 48,000 | — | |
| Mar 30, 2016 AForm 4 → | Apr 1, 5:20 pm EDT | Joseph William StaufferChief Medical Officer | 66,000 | — | — | 66,000 | — | |
| Mar 30, 2016 AForm 4 → | Apr 1, 5:19 pm EDT | Derek T ChalmersPresident & CEO, Director | 194,000 | — | — | 194,000 | — | |
| Mar 16, 2016 MForm 4 → | Mar 17, 8:22 pm EDT | Josef SchoellChief Financial Officer | 18,000 | — | — | 0 | — | |
| Mar 15, 2016 MForm 4 → | Mar 17, 5:59 pm EDT | Derek T ChalmersPresident & CEO, Director | 10,000 | — | — | 30,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 17, 5:59 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 60,000 | — | — | 60,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 17, 5:58 pm EDT | Josef SchoellChief Financial Officer | 30,000 | — | — | 30,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 17, 5:57 pm EDT | Derek T ChalmersPresident & CEO, Director | 165,000 | — | — | 165,000 | — | |
| Jun 8, 2015 AForm 4 → | Jun 10, 5:47 pm EDT | Dean SlagelDirector | 13,500 | — | — | 13,500 | — | |
| Jun 8, 2015 AForm 4 → | Jun 10, 5:44 pm EDT | Martin VogelbaumDirector | 13,500 | — | — | 13,500 | — | |
| Jun 8, 2015 AForm 4 → | Jun 10, 5:39 pm EDT | Jeffrey L. IvesDirector | 13,500 | — | — | 13,500 | — | |
| Jun 8, 2015 AForm 4 → | Jun 10, 5:37 pm EDT | Harrison M Bains Jr.Director | 13,500 | — | — | 13,500 | — | |
| Mar 9, 2015 MForm 4 → | Mar 11, 4:54 pm EDT | Frederique Menzaghi Ph.D.VP-Research & Development | 20,000 | — | — | 0 | — |